COVID-19

Showing NaN - NaN of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in New York (GIGA-2050)

Terminated
  • COVID-19
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jan 11, 2022

COVID-19 Trial in New York (Tocilizumab)

Active, not recruiting
  • COVID-19
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

COVID-19 Trial in United States (CytoSorb 300 mL device)

Completed
  • COVID-19
  • CytoSorb 300 mL device
  • Aurora, Colorado
  • +6 more
Jan 20, 2022

COVID-19, SARS-CoV-2 Trial in Worldwide (Enoxaparin, Apixaban)

Recruiting
  • COVID-19
  • SARS-CoV-2
  • New York, New York
  • +20 more
Jan 18, 2022

COVID-19 Trial in New York (COVID-HIGIV, Placebo (saline))

Completed
  • COVID-19
  • COVID-HIGIV
  • Placebo (saline)
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 15, 2021

COVID-19 Survivors

Recruiting
  • COVID-19 Pneumonia
  • +6 more
  • Cardiac MRI
  • +3 more
  • Brooklyn, New York
  • +2 more
Dec 20, 2021

COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,

Completed
  • COVID-19
  • +3 more
  • Hydroxychloroquine Sulfate
  • Ascorbic Acid
  • Los Angeles, California
  • +7 more
Dec 14, 2021

COVID-19 Trial in United States (Gimsilumab, Placebo)

Completed
  • COVID-19
  • Phoenix, Arizona
  • +32 more
Dec 10, 2021

COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
  • COVID-19
    • New York, New York
      Columbia University Irving Medical Center
    Nov 12, 2021

    COVID-19, Cancer Trial in United States (drug, other, radiation)

    Terminated
    • COVID-19
    • Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Oct 25, 2021

    COVID-19 Trial in United Kingdom, United States (Rivaroxaban, Placebo)

    Terminated
    • COVID-19
    • Rogers, Arkansas
    • +19 more
    Oct 20, 2021

    COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)

    Completed
    • COVID-19
    • Aurora, Colorado
    • +33 more
    Oct 8, 2021

    SARS-CoV-2/COVID-19 Prevalence Study

    Completed
    • COVID-19
      • Aurora, Colorado
      • +14 more
      Sep 29, 2021

      COVID19, COVID-19, COVID Trial in United States (Pacritinib, Placebo)

      Terminated
      • COVID19
      • +2 more
      • Orange, California
      • +20 more
      Sep 23, 2021

      COVID-19 Trial in United States (Sarilumab, Placebo)

      Completed
      • COVID-19
      • Los Angeles, California
      • +61 more
      Sep 16, 2021

      COVID-19 Trial in New York (AT-001)

      Completed
      • COVID-19
      • New York, New York
        NYU Langone Health
      Sep 10, 2021

      COVID-19 Trial in United States (Acalabrutinib)

      Completed
      • COVID-19
      • Anniston, Alabama
      • +30 more
      Sep 8, 2021

      SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

      Active, not recruiting
      • SARS-CoV-2
      • COVID-19
      • Sample collection
      • Birmingham, Alabama
      • +52 more
      Sep 3, 2021

      COVID-19, COVID, Coronavirus Trial in New York (Continuous Positive Airway Pressure)

      Terminated
      • COVID-19
      • +2 more
      • Continuous Positive Airway Pressure
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Aug 12, 2021

      Predictors of Severe COVID-19 Outcomes

      Active, not recruiting
      • Acute Respiratory Distress Syndrome
      • COVID-19
        • Tucson, Arizona
        • +7 more
        Aug 16, 2021

        COVID-19 in Patients With Chronic Liver Diseases

        Completed
        • COVID-19
        • Chronic Liver Disease
        • Prospective Chart Review
        • Phoenix, Arizona
        • +22 more
        Aug 5, 2021

        COVID-19, Pneumonia Trial in Worldwide (Heparin)

        Completed
        • COVID-19
        • Pneumonia
        • Atlanta, Georgia
        • +59 more
        Jul 26, 2021

        COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)

        Recruiting
        • COVID-19
        • Birmingham, Alabama
        • +18 more
        Jul 19, 2021

        COVID-19 Trial in El Centro, New York, Philadelphia (CPI-006, Standard of Care)

        Completed
        • COVID-19
        • El Centro, California
        • +2 more
        Jul 20, 2021

        COVID-19 Trial in New York (Saline oral/nasal rinse, 0.5% Povidone/Iodine oral/nasal rinse, 0.12% Chlorhexidine oral/nasal

        Withdrawn
        • COVID-19
        • Saline oral/nasal rinse
        • +2 more
        • New York, New York
          NYU Langone Health
        May 6, 2021